Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

16 questions · 17 findings · 4 reviews

No studies found 6 · 35.3%GRADE not reported 5 · 29.4%Very low 4 · 23.5%Low 2 · 11.8%Moderate 0 · 0%High 0 · 0%

Lactobacillus vs placebo

Episodes of confirmed vaginal candidiasis fungal smear · prevention and treatment of vulvovaginal candidiasis in women with HIV infection

Lactobacillus showed no clear difference in episodes of confirmed vaginal candidiasis fungal smear compared with placebo (low certainty).

1 finding from 1 review

Lactobacillus vs Clotrimazole 10 mg (partially absorbed)

Episodes of confirmed vaginal candidiasis fungal smear · prevention and treatment of vulvovaginal candidiasis in women with HIV infection

Lactobacillus showed no clear difference in episodes of confirmed vaginal candidiasis fungal smear compared with clotrimazole (low certainty).

1 finding from 1 review

Kefir ( Lactobacillus bacteria) vs no intervention

Pain intensity (measure on a 0‐3 four‐point scale) · people with inflammatory bowel disease
2 findings from 1 review

Lactobacillus brevis CD2 lozenges vs placebo control

OLT, VSC and breath print scores · Adolescents and adults aged over 16 years with clinical or self-assessed halitosis of oral origin; excluding induced or physiological…
1 finding from 1 review
  • Interventions for managing halitosis 2019 · Cochrane All outcomes
    Marchetti 2015 (2-arm RCT) compared Lactobacillus brevis CD2 lozenges versus placebo lozenges (OLT, VSC and breath print). The study did not report any usable data and hence could not be included in the meta-analysis.
    1 study
    GRADE not reported

Lactobacillus salivarius WB21 tablets vs placebo (3 tablets/4 times a day

OLT and VSC scores · Adolescents and adults aged over 16 years with clinical or self-assessed halitosis of oral origin; excluding induced or physiological…
1 finding from 1 review
  • Interventions for managing halitosis 2019 · Cochrane All outcomes
    Suzuki 2014 (cross-over RCT) compared Lactobacillus salivarius WB21 tablets versus placebo tablets (OLT and VSC by gas chromatography). The trial did not give usable data and we could not extract data from the graph.
    1 study
    GRADE not reported

Lactobacillus beta lactoperoxidase (LPO) tablets vs placebo (3 tablets/4 times a day

Volatile sulphur compounds (VSC), gas chromatography · Adolescents and adults aged over 16 years with clinical or self-assessed halitosis of oral origin; excluding induced or physiological…
1 finding from 1 review
  • Interventions for managing halitosis 2019 · Cochrane All outcomes
    Nakano 2017 (2-arm trial) compared Lactobacillus beta LPO tablets versus placebo tablets (VSC by OralChroma). The trial did not report any usable data and hence could not be included in the analysis.
    1 study
    GRADE not reported